Electrocardiographic abnormalities in patients with cluster headache on verapamil therapy

Neurology

Volumn 69, Issue 7, 2007, Pages 668-675

  Cohen, Anna S ^a   Matharu, Manjit S ^a   Goadsby, Peter J ^a,b,c  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VERAPAMIL;

ADULT; ANKLE EDEMA; ARTHRALGIA; ARTICLE; ATRIOVENTRICULAR JUNCTION ARRHYTHMIA; BRADYCARDIA; CLUSTER HEADACHE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; FEMALE; GINGIVA HYPERPLASIA; HEART ARRHYTHMIA; HEART BLOCK; HEART PALPITATION; HEART RIGHT BUNDLE BRANCH BLOCK; HEARTBURN; HOSPITAL ADMISSION; HUMAN; LETHARGY; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MYALGIA; PARESTHESIA; POSITIONAL DIZZINESS; PR INTERVAL; PRIORITY JOURNAL; SEX DIFFERENCE; THORAX PAIN;

ADOLESCENT; ADULT; AGED; CLUSTER HEADACHE; COHORT STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; VERAPAMIL;

EID: 34547889122     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000267319.18123.d3     Document Type: Article

References (40)

1. Headache Classification Committee of The International Headache Society. The International Classification of Headache Disorders (second edition). Cephalalgia 2004;24(suppl 1):1-160.
2. Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic features, including new cases. Brain 1997;120:193-209.
3. Goadsby PJ. Pathophysiology of cluster headache: a trigeminal autonomic cephalgia. Lancet Neurol 2002;1:37-43.
4. Ekbom K, Waldenlind E, Cole JA, Pilgrim AJ, Kirkham A. Sumatriptan in chronic cluster headache: results of continuous treatment for eleven months. Cephalalgia 1992;12:254-256.
5. Ekbom K, Monstad I, Prusinski A, Cole JA, Pilgrim AJ, Noronha D. Subcutaneous sumatriptan in the acute treatment of cluster headache: a dose comparison study. Acta Neurol Scand 1993;88:63-69.
6. Ekbom K, Krabbe A, Micelli G, et al. Cluster headache attacks treated for up to three months with subcutaneous sumatriptan (6 mg). Cephalalgia 1995;15:230-236.
7. van Vliet JA, Bahra A, Martin V, et al. Intranasal sumatriptan in cluster headache- randomized placebo-controlled double-blind study. Neurology 2003;60:630-633.
8. Cittadini E, May A, Straube A, Evers S, Bussone G, Goadsby PJ. Effectiveness of intranasal zolmitriptan in acute cluster headache. A randomized, placebo-controlled, double-blind crossover study. Arch Neurol 2006;63:1537-1542.
9. Fogan L. Treatment of cluster headache: a double blind comparison of oxygen vs air inhalation. Arch Neurol 1985;42:362-363.
10. Gabai IJ, Spierings ELH. Prophylactic treatment of cluster headache with verapamil. Headache 1989;29:167-168.
11. Bussone G, Leone M, Peccarisi C, et al. Double blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache 1990;30:411-417.
12. Leone M, D'Amico D, Frediani F, et al. Verapamil in the prophylaxis of episodic cluster headache: a double-blind study versus placebo. Neurology 2000;54:1382-1385.
13. Thulin T. Calcium antagonists- assessments of side effects. Scan J Prim Health Care 1990;1:84.
14. Dougall HT, McLay J. A comparative review of the adverse effects of calcium antagonists. Drug Safety 1996;15:91-106.
15. Jonsdottir M, Meyer JS, Rogers RL. Efficacy, side effects and tolerance compared during headache treatment with three different calcium blockers. Headache 1987;27:364-369.
16. Afridi S, Bacon C, Bowling J, Goadsby PJ. Verapamil and lymphomatoid papulosis in chronic cluster headache. J Neurol 2004;251:473-475.
17. Matharu MS, van Vliet JA, Ferrari MD, Goadsby PJ. Verapamil-induced gingival enlargement in cluster headache. J Neurol Neurosurg Psychiatry 2005;76:124-127.
18. Olesen J, Goadsby PJ. Cluster Headache and Related Conditions. Oxford: Oxford University Press, 1999.
19. Matharu MS, Goadsby PJ. Trigeminal autonomic cephalgias. J Neurol Neurosurg Psychiatry 2002;72:ii19-ii26.
20. Naylor WG. Calcium antagonists. London: Academic Press, 1988.
21. Cohen AS, Matharu MS, Goadsby PJ. ECG abnormalities on verapamil in cluster headache. Cephalalgia 2005;25:1200.
22. Black HR, Elliott WJ, Grandits G, et al. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA 2003;289:2073-2082.
23. Pepine CJ, Handberg EM, Cooper-DeHoff RM, et al. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA 2003;290:2805-2816.
24. Seipel L, Breithardt G. Electrophysiological actions of calcium antagonists in the heart. Cardiology 1982;69(suppl):105-116.
25. Frishman W, Kirsten E, Klein M, et al. Clinical relevance of verapamil plasma levels in stable angina pectoris. Am J Cardiol 1982;50:1180-1184.
26. Ranade VV, Somberg JC. Chiral cardiovascular drugs: an overview. Am J Ther 2005;12:439-459.
27. Bexton RS, Camm AJ. First degree atrioventricular block. Eur Heart J 1984;5(suppl A):107-109.
28. Mymin D, Mathewson FA, Tate RB, Manfreda J. The natural history of primary first-degree atrioventricular heart block. N Engl J Med 1986;315:1183-1187.
29. Gupta SK, Hwang S, Atkinson L, Longstreth J. Simultaneous first-order and capacity-limited elimination kinetics after oral administration of verapamil. J Clin Pharmacol 1996;36:25-34.
30. Zeltser D, Justo D, Halkin A, et al. Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug. J Am Coll Cardiol 2004;44:105-108.
31. Price WA, Giannini AJ. Neurotoxicity caused by lithium-verapamil synergism. J Clin Pharmacol 1986;26:717-719.
32. Price WA, Shalley JE. Lithium-verapamil toxicity in the elderly. J Am Geriatr Soc 1987;35:177-178.
33. MaassenVanDenBrink A, Reekers M, Bax WA, Ferrari MD, Saxena PR. Coronary side-effect potential of current and prospective antimigraine drugs. Circulation 1998;98:25-30.
34. Blakeborough P, Fowler PA, Ashford EA. The use of sumatriptan in patients taking migraine prophylactic agents. Cephalalgia 1993;13(suppl):163.
35. Bahra A, May A, Goadsby PJ. Cluster headache: a prospective clinical study in 230 patients with diagnostic implications. Neurology 2002;58:354-361.
36. Stamler J, Stamler R, Neaton JD, et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 1999;282:2012-2018.
37. Sharma SB, Dwivedi S, Prabhu KM, Singh G, Kumar N, Lal MK. Coronary risk variables in young asymptomatic smokers. Ind J Med Res 2005;122:205-210.
38. Mehta MC, Jain AC, Mehta A, Billie M. Cardiac arrhythmias following intravenous nicotine: experimental study in dogs. J Cardiovasc Pharmacol Ther 1997;2:291-298.
39. Bahra A, Goadsby PJ. Diagnostic delays and mismanagement in cluster headache. Acta Neurol Scand 2004;109:175-179.
40. Matharu MS, Boes CJ, Goadsby PJ. Management of trigeminal autonomic cephalalgias and hemicrania continua. Drugs 2003;63:1637-1677.